<DOC>
	<DOCNO>NCT00559286</DOCNO>
	<brief_summary>The hypothesis present study : Telmisartan induces increase eNOS activity RBC result enhance intravascular NO bioavailability , ameliorate RBC deformability reduction RBC platelet aggregation . This could potential mechanism improvement microcirculatory disorder , especially patient diabetes mellitus arterial hypertension , treat Telmisartan .</brief_summary>
	<brief_title>Effect Known Antihypertensive Drug Telmisartan Red Blood Cells Circulation Smallest Blood Vessels</brief_title>
	<detailed_description>Recently , could show renin-angiotensin-system ( RAS ) influence different signal transduction pathway within red blood cell ( RBC ) . This include Na+/H+ exchange activity , Ca2+-ATP-ase mediate Ca2+efflux , erythropoietin- dependent production RBC , RBC deformability , RBC aggregation interaction RBC platelet . Recent study experiment , do group , focus oxidative nitrosative metabolism NO within blood . The interaction RAS endothelial NO well known describe detail . Based wide experience research field NO metabolism , characterize recently active endothelial-type NO-synthase RBC biochemical , functional molecular level . Erythrocyte-derived NO formation serve important regulatory function essential adequate passage blood vasculature . Here aim treat patient diabetes mellitus arterial hypertension Telmisartan angiotensin receptor antagonist . Efficacy parameter study study : ) RBC deformability , RBC aggregation , ii ) RBC dependent production nitric oxide well detection eNOS activity RBC iii ) indices microcirculatory perfusion . This project could broaden view effect Telmisartan treatment microcirculatory disorder patient diabetes mellitus arterial hypertension , exhibit reduce NO bioavailability RBC function .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>Men old 18 year Diabetes mellitus type 2 define accord criterion American Diabetes Association Arterial hypertension define accord criterion Joint National Committtees ( JNC 7 ) Given informed consent Serve heart failure Serve aortic valve stenosis hypertrophy obstructive cardiomyopathy Relevant cardiac arrhythmia Acute myocardial infarction within last 4 week renal failure bilateral renal artery stenosis liver diseases primary hyperaldosteronism orthostatic hypotension ( systolic blood pressure &lt; 100mmHg ) hypokalemia , hyponatremia , hypercalcemia , symptomatic hyperuricemia inflammatory disease malignant disease previous intolerance AT1 receptor antagonist and/or sulfonamide current therapy insulin sensitizer current therapy digoxin know abuse alcohol drug</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>perfusion</keyword>
	<keyword>microcirculation</keyword>
	<keyword>RBC function</keyword>
	<keyword>NO metabolism</keyword>
	<keyword>AT receptor blocker</keyword>
</DOC>